ovarian cancer

Ricardo Cubedo, MD
November 14, 2019 · Greg Guthrie, ASCO staff
Dr. Ricardo Cubedo describes 3 research highlights from the ESMO 2019 Congress, including targeted therapy for ovarian cancer, immunotherapy for lung cancer, and more study data on targeted tumor-agnostic treatment. Read More >>
2019 ASCO ® Annual Meeting; #ASCO19
June 2, 2019 · Monika Sharda, ASCO staff
The ASCO Annual Meeting is where many new cancer research findings are announced. Today’s key research highlights include an effective medication for metastatic prostate cancer, targeted therapy that slows the growth of metastatic pancreatic cancer, how socioeconomic factors may affect survival for multiple myeloma, and how the ACA resulted in earlier treatment and improved equality in care. Read More >>
May 10, 2019 · Claire Smith, ASCO staff
Kimberly Pena was 31 when she was diagnosed with breast cancer, the same age her mother was when she was diagnosed more than 3 decades earlier. She shares her experience with cancer, treatment, and trying to convince her family to be tested for the BRCA genetic mutation. Read More >>
April 9, 2019 · Monika Sharda, ASCO staff
In this podcast interview, Dr. Allison W. Kurian talks about a recent study showing that most women with breast or ovarian cancer do not receive genetic testing. Read More >>
February 7, 2019 · Abhishek Kumar, MD
If you’ve been diagnosed with a gynecologic cancer, learning about your disease and its treatment can help you make well-informed decisions and regain a sense of control. Read More >>

Pages